Stock BCYP BIG CYPR
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News BIG CYPR

Equities

BCYP

US0891151096

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
UNAUDITED PRO FORMA COMBINED CONDENSED CONSOLIDATED FINANCIAL INFORMATION - Form 8-K
PU
Big Cypress Acquisition Corp.(NasdaqCM:BCYP) dropped from NASDAQ Composite Index
CI
SAB Biotherapeutics, Inc. completed the acquisition of Big Cypress Acquisition Corp. in a reverse merger transaction.
CI
BIG CYPRESS ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Big Cypress Acquisition Corp. Announces Board Changes
CI
Big Cypress Acquisition Corp. : Stockholders Approve Business Combination with SAB Biotherapeutics
PR
SAB Corporate Presentation
PU
BIG CYPRESS ACQUISITION CORP. : Other Events (form 8-K)
AQ
R&D Day Presentation
PU
BIG CYPRESS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Big Cypress Acquisition : SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021
BU
Big Cypress Acquisition : SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19
BU
SAB Biotherapeutics : Appoints Russell Beyer Chief Financial Officer
BU
SAB Biotherapeutics : Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
BU
Big Cypress Acquisition Corp : Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics
PR
Big Cypress Acquisition : SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19
BU
SAB Biotherapeutics : Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
BU
SAB Biotherapeutics : to Present at Upcoming September Virtual Investor Conferences
BU
Big Cypress Acquisition : FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Form 8-K)
PU
BIG CYPRESS ACQUISITION CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BCYP Stock
  4. News BIG CYPR